Mereo BioPharma Group plc American Depositary Shares (MREO) is a publicly traded Healthcare sector company. As of July 27, 2026, MREO trades at $0.29 with a market cap of $45.94M and a P/E ratio of -5.76. MREO moved +0.10% today. Year to date, MREO is -22.32%; over the trailing twelve months it is -83.46%. Its 52-week range spans $0.20 to $3.94. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces MREO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MREO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.29 |
| Market Cap | $45.94M |
| P/E Ratio | -5.76 |
| EPS | $-0.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.94 |
| 52-Week Low | $0.20 |
| Volume | 259.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $500.00K |
| Net Income | $-41.88M |
| Gross Margin | 0.00% |
3 analysts cover MREO: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.00.